Balance Sheet Fuchs SE

Stocks

FPE3

DE000A3E5D64

Commodity Chemicals

Real-time Estimate Tradegate Other stock markets 06:30:59 13/07/2026 pm IST			5-day change	1st Jan Change
39.32 ^EUR	+0.31%		-0.56%	+2.62%

10/07	FUCHS SE : JP Morgan gives a Buy rating	ZD
09/07	Fuchs SE Announces Step Down of Ingeborg Neumann from the Supervisory Board	CI

f7d0b18c95a3241c627594bf6e072f._TqQPY1_FUcI6lnb0BFb06OrSy4ZzSkY8m78O2p5zYo.ngu9Uu9PJ3VhqT2Bg1ZssJrCJkdOmWh2lxSyWAMVgMC4Quhu2h5cI2aMDA

Published financial data: FUCHS SE

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	287.1Cr	341.2Cr	354.1Cr	352.5Cr	356.3Cr
Total Revenues	287.1Cr	341.2Cr	354.1Cr	352.5Cr	356.3Cr
Cost of Goods Sold, Total	191.4Cr	236.6Cr	240.5Cr	231.7Cr	232.6Cr
Gross Profit	96Cr	104.6Cr	113.6Cr	120.8Cr	123.7Cr
Selling General & Admin Expenses, Total	55Cr	61Cr	65Cr	70Cr	72Cr
R&D Expenses	5.7Cr	6.7Cr	6.9Cr	7.7Cr	8.1Cr
Other Operating Expenses	-90L	10L	30L	-20L	70L
Other Operating Expenses, Total	60Cr	68Cr	72Cr	77Cr	80Cr
Operating Income	36Cr	36Cr	41Cr	44Cr	43Cr
Interest Expense, Total	-50L	-90L	-1.2Cr	-90L	-1.1Cr
Interest And Investment Income	-	10L	20L	30L	40L
Net Interest Expenses	-50L	-80L	-1Cr	-60L	-70L
Income (Loss) On Equity Invest.	90L	90L	70L	80L	1Cr
Currency Exchange Gains (Loss)	10L	-60L	-40L	-20L	0
EBT, Excl. Unusual Items	36Cr	36Cr	41Cr	44Cr	44Cr
Restructuring Charges	-20L	-20L	-40L	-80L	-60L
Merger & Related Restructuring Charges	-	-	-	-	-
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Assets	0	10L	40L	0	-20L
Asset Writedown	-	-10L	-40L	-	-
EBT, Incl. Unusual Items	36Cr	36Cr	40Cr	43Cr	43Cr
Income Tax Expense	10Cr	9.7Cr	12Cr	13Cr	12Cr
Earnings From Continuing Operations	25Cr	26Cr	28Cr	30Cr	31Cr
Net Income to Company	25Cr	26Cr	28Cr	30Cr	31Cr
Minority Interest	-10L	-10L	-10L	-	-
Net Income - (IS)	25Cr	26Cr	28Cr	30Cr	31Cr
Net Income to Common Incl Extra Items	25Cr	26Cr	28Cr	30Cr	31Cr
Net Income to Common Excl. Extra Items	25Cr	26Cr	28Cr	30Cr	31Cr
Per Share Items
Net EPS - Basic	1.82	1.87	2.09	2.3	2.34
Basic EPS - Continuing Operations	1.82	1.87	2.09	2.3	2.34
Basic Weighted Average Shares Outstanding	14Cr	14Cr	13Cr	13Cr	13Cr
Net EPS - Diluted	1.82	1.87	2.09	2.3	2.34
Diluted EPS - Continuing Operations	1.82	1.87	2.09	2.3	2.34
Diluted Weighted Average Shares Outstanding	14Cr	14Cr	13Cr	13Cr	13Cr
Normalized Basic EPS	1.61	1.61	1.88	2.07	2.08
Normalized Diluted EPS	1.61	1.61	1.88	2.07	2.08
Dividend Per Share	1.03	1.07	1.11	1.17	1.23
Payout Ratio	54.15	54.83	51.06	48.34	50
American Depositary Receipts Ratio (ADR)	0.25	0.25	0.25	0.25	0.25
Supplemental Items
EBITDA	43Cr	45Cr	50Cr	52Cr	52Cr
EBITA	38Cr	39Cr	44Cr	46Cr	45Cr
EBIT	36Cr	36Cr	41Cr	44Cr	43Cr
EBITDAR	44Cr	45Cr	50Cr	53Cr	52Cr
Effective Tax Rate - (Ratio)	29.05	27.17	29.78	29.44	28.5
Current Domestic Taxes	4.2Cr	3.9Cr	5.6Cr	4.9Cr	5.2Cr
Current Foreign Taxes	6.3Cr	6.3Cr	6.8Cr	7.9Cr	8Cr
Total Current Taxes	10Cr	10Cr	12Cr	13Cr	13Cr
Deferred Domestic Taxes	20L	-10L	-	10L	-20L
Deferred Foreign Taxes	-30L	-40L	-40L	-30L	-80L
Total Deferred Taxes	-10L	-50L	-40L	-20L	-1Cr
Normalized Net Income	22Cr	22Cr	25Cr	27Cr	27Cr
Interest on Long-Term Debt	10L	10L	10L	20L	30L
Non-Cash Pension Expense	0	0	0	0	0
Supplemental Operating Expense Items
Marketing Expenses	1.4Cr	1.4Cr	1.7Cr	2Cr	2Cr
Selling and Marketing Expenses	40Cr	45Cr	47Cr	50Cr	52Cr
General and Administrative Expenses	15Cr	16Cr	17Cr	19Cr	20Cr
Research And Development Expense From Footnotes	5.9Cr	6.9Cr	7.1Cr	7.9Cr	8.4Cr
Net Rental Expense, Total	50L	50L	60L	60L	50L
Imputed Operating Lease Interest Expense	50.63L	31.58L	47.6L	49.37L	42.93L
Imputed Operating Lease Depreciation	-63.28T	18.42L	12.4L	10.63L	7L
Maintenance & Repair Expenses, Total	2.5Cr	2.8Cr	3.2Cr	3.1Cr	3.4Cr
Stock-Based Comp., Other (Total)	11.97L	11.13L	14.05L	17.73L	18.74L
Total Stock-Based Compensation	11.97L	11.13L	14.05L	17.73L	18.74L

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	15Cr	12Cr	18Cr	15Cr	24Cr
Total Cash And Short Term Investments	15Cr	12Cr	18Cr	15Cr	24Cr
Accounts Receivable, Total	43Cr	51Cr	50Cr	52Cr	52Cr
Other Receivables	1.3Cr	2.1Cr	1.9Cr	3.1Cr	4.3Cr
Total Receivables	45Cr	53Cr	52Cr	55Cr	56Cr
Inventory	51Cr	64Cr	52Cr	57Cr	57Cr
Other Current Assets, Total	2.2Cr	3.4Cr	2.3Cr	1.4Cr	1.2Cr
Total Current Assets	112.1Cr	131.8Cr	124.3Cr	128.5Cr	138.1Cr
Gross Property Plant And Equipment	126.8Cr	133.3Cr	136.7Cr	150.5Cr	151Cr
Accumulated Depreciation	-52Cr	-58Cr	-62Cr	-69Cr	-72Cr
Net Property Plant And Equipment	74Cr	75Cr	75Cr	81Cr	79Cr
Long-term Investments	5Cr	6.1Cr	6.1Cr	6.8Cr	6.5Cr
Goodwill	25Cr	25Cr	25Cr	31Cr	31Cr
Other Intangibles, Total	10Cr	8.9Cr	7.1Cr	7.8Cr	10Cr
Accounts Receivable Long-Term	10L	10L	10L	10L	-
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	3.5Cr	3.8Cr	3.8Cr	3.9Cr	4.4Cr
Other Long-Term Assets, Total	90L	1.1Cr	90L	1.7Cr	1.3Cr
Total Assets	231.1Cr	252.3Cr	242.3Cr	261Cr	270.3Cr
Liabilities
Accounts Payable, Total	23Cr	23Cr	26Cr	28Cr	31Cr
Accrued Expenses, Total	11Cr	12Cr	13Cr	14Cr	14Cr
Current Portion of Long-Term Debt	2.7Cr	15Cr	2.6Cr	4.8Cr	2.6Cr
Current Portion of Leases	80L	70L	90L	1.2Cr	1.2Cr
Current Income Taxes Payable	2.4Cr	1.8Cr	3.2Cr	4.1Cr	3.5Cr
Unearned Revenue Current, Total	2.1Cr	1.7Cr	2Cr	1.8Cr	2Cr
Other Current Liabilities	3.8Cr	4.7Cr	4.5Cr	4.3Cr	5.1Cr
Total Current Liabilities	45Cr	59Cr	52Cr	58Cr	59Cr
Long-Term Debt	-	30L	70L	1Cr	60L
Long-Term Leases	1.4Cr	1.5Cr	2.1Cr	4.2Cr	4.9Cr
Pension & Other Post Retirement Benefits	2.8Cr	70L	1Cr	1.1Cr	80L
Deferred Tax Liability Non Current	4.8Cr	5.3Cr	4.6Cr	5.3Cr	5.1Cr
Other Non Current Liabilities	1.2Cr	1Cr	1Cr	1.4Cr	1.6Cr
Total Liabilities	56Cr	68Cr	62Cr	71Cr	72Cr
Common Stock, Total	14Cr	14Cr	14Cr	13Cr	13Cr
Retained Earnings	25Cr	26Cr	28Cr	30Cr	31Cr
Comprehensive Income and Other	136.1Cr	144Cr	137.9Cr	146.4Cr	153.9Cr
Total Common Equity	175.3Cr	183.8Cr	180Cr	189.7Cr	197.6Cr
Minority Interest	30L	30L	40L	30L	30L
Total Equity	175.6Cr	184.1Cr	180.4Cr	190Cr	197.9Cr
Total Liabilities And Equity	231.1Cr	252.3Cr	242.3Cr	261Cr	270.3Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	14Cr	14Cr	13Cr	13Cr	13Cr
ECS Total Common Shares Outstanding	14Cr	14Cr	13Cr	13Cr	13Cr
Book Value / Share	12.61	13.22	13.53	14.48	15.08
Tangible Book Value	140.2Cr	149.5Cr	148Cr	151Cr	156.3Cr
Tangible Book Value Per Share	10.09	10.76	11.12	11.53	11.93
Total Debt	4.9Cr	18Cr	6.3Cr	11Cr	9.3Cr
Net Debt	-9.7Cr	6Cr	-11Cr	-4.1Cr	-15Cr
Debt Equivalent of Unfunded Proj. Benefit Obligation	2.3Cr	0	40L	40L	-10L
Debt Equivalent Oper. Leases	4Cr	4Cr	4.8Cr	4.8Cr	4Cr
Minority Interest, Total (Incl. Fin. Div)	30L	30L	40L	30L	30L
Equity Method Investments, Total	4.3Cr	5.4Cr	5.5Cr	6.2Cr	5.9Cr
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	22Cr	26Cr	20Cr	22Cr	21Cr
Inventories - Work In Process, Total	2.4Cr	3.7Cr	3Cr	2.9Cr	3.3Cr
Inventories - Finished Goods, Total	27Cr	34Cr	29Cr	32Cr	32Cr
Land - (BS)	48Cr	51Cr	53Cr	59Cr	59Cr
Machinery, Total	73Cr	77Cr	80Cr	88Cr	88Cr
Full Time Employees	5.98T	6.1T	6.27T	6.78T	6.88T
Accumulated Allowance for Doubtful Accounts (Supple)	1.1Cr	1.4Cr	1.4Cr	1.3Cr	1.3Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	25Cr	26Cr	28Cr	30Cr	31Cr
Depreciation & Amortization - CF	6.4Cr	7Cr	7Cr	7.4Cr	7.8Cr
Amortization of Goodwill and Intangible Assets - (CF)	2.2Cr	2.3Cr	2.3Cr	2.3Cr	2.1Cr
Depreciation & Amortization, Total	8.6Cr	9.3Cr	9.3Cr	9.7Cr	9.9Cr
(Gain) Loss From Sale Of Asset	-	-10L	-30L	-	10L
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Asset Writedown & Restructuring Costs	-	10L	50L	-	-
(Income) Loss On Equity Investments - (CF)	-90L	-10L	-10L	-30L	-20L
Stock-Based Compensation (CF)	10L	-	-	-	-
Other Operating Activities, Total	50L	-60L	-1Cr	-40L	-80L
Change In Accounts Receivable	-4.5Cr	-7.7Cr	-60L	-40L	-1.5Cr
Change In Inventories	-13Cr	-13Cr	8.9Cr	-2.2Cr	-1.8Cr
Change In Accounts Payable	2.5Cr	20L	3.4Cr	1.3Cr	4.8Cr
Change in Other Net Operating Assets	-1.5Cr	-1.1Cr	6Cr	1.1Cr	-50L
Cash from Operations	17Cr	13Cr	54Cr	39Cr	41Cr
Capital Expenditure	-8Cr	-6.9Cr	-8.3Cr	-8.3Cr	-9.2Cr
Sale of Property, Plant, and Equipment	10L	20L	50L	10L	20L
Cash Acquisitions	-2.9Cr	-20L	-40L	-10Cr	-2.7Cr
Divestitures	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-	-	-	-20L	-
Cash from Investing	-11Cr	-6.9Cr	-8.2Cr	-18Cr	-12Cr
Long-Term Debt Issued, Total	50L	12Cr	-	50L	-
Total Debt Issued	50L	12Cr	-	50L	-
Long-Term Debt Repaid, Total	-	-	-13Cr	-	-3.7Cr
Total Debt Repaid	-	-	-13Cr	-	-3.7Cr
Repurchase of Common Stock	-	-6.2Cr	-12Cr	-7.9Cr	-
Common Dividends Paid	-14Cr	-14Cr	-14Cr	-15Cr	-15Cr
Common & Preferred Stock Dividends Paid	-14Cr	-14Cr	-14Cr	-15Cr	-15Cr
Other Financing Activities, Total	-	-10L	-10L	-80L	-
Cash from Financing	-13Cr	-8.6Cr	-40Cr	-23Cr	-19Cr
Foreign Exchange Rate Adjustments	80L	-	-50L	10L	-80L
Net Change in Cash	-6.3Cr	-2.7Cr	5.6Cr	-2.2Cr	9.1Cr
Supplemental Items
Cash Interest Paid	50L	90L	1.2Cr	90L	1.1Cr
Cash Income Tax Paid (Refund)	12Cr	11Cr	11Cr	12Cr	14Cr
Levered Free Cash Flow	3.89Cr	3.8Cr	45Cr	25Cr	30Cr
Unlevered Free Cash Flow	4.21Cr	4.36Cr	46Cr	25Cr	31Cr
Change In Net Working Capital	19Cr	21Cr	-19Cr	3.4Cr	-3.1Cr
Net Debt Issued / Repaid	50L	12Cr	-13Cr	50L	-3.7Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	10.01	9.41	10.46	10.83	10.19
Return on Total Capital	12.99	11.9	13.31	14.05	13.25
Return On Equity %	15.23	14.46	15.53	16.31	15.78
Return on Common Equity	15.19	14.42	15.5	16.34	15.8
Margin Analysis
Gross Profit Margin %	33.33	30.66	32.08	34.27	34.72
SG&A Margin	19.3	18	18.36	19.77	20.1
EBITDA Margin %	15.05	13.1	14.04	14.78	14.51
EBITA Margin %	13.13	11.34	12.34	13.02	12.74
EBIT Margin %	12.36	10.67	11.69	12.37	12.15
Income From Continuing Operations Margin %	8.85	7.62	7.99	8.57	8.59
Net Income Margin %	8.81	7.59	7.96	8.57	8.59
Net Avail. For Common Margin %	8.81	7.59	7.96	8.57	8.59
Normalized Net Income Margin	7.8	6.55	7.16	7.73	7.65
Levered Free Cash Flow Margin	1.36	1.11	12.73	7.05	8.52
Unlevered Free Cash Flow Margin	1.47	1.28	12.94	7.21	8.71
Asset Turnover
Asset Turnover	1.3	1.41	1.43	1.4	1.34
Fixed Assets Turnover	3.98	4.56	4.72	4.51	4.45
Receivables Turnover (Average Receivables)	7.14	7.24	7	6.9	6.88
Inventory Turnover (Average Inventory)	4.42	4.14	4.15	4.25	4.11
Short Term Liquidity
Current Ratio	2.47	2.22	2.37	2.22	2.32
Quick Ratio	1.31	1.09	1.33	1.21	1.35
Operating Cash Flow to Current Liabilities	0.37	0.22	1.03	0.67	0.68
Days Sales Outstanding (Average Receivables)	51.11	50.39	52.11	53.06	53.06
Days Outstanding Inventory (Average Inventory)	82.57	88.09	87.95	86.17	88.9
Average Days Payable Outstanding	37.7	33.51	39.06	41.95	46.55
Cash Conversion Cycle (Average Days)	95.98	104.96	100.99	97.28	95.41
Long Term Solvency
Total Debt/Equity	2.79	9.72	3.49	5.89	4.7
Total Debt / Total Capital	2.71	8.86	3.37	5.57	4.49
LT Debt/Equity	0.8	0.98	1.55	2.74	2.78
Long-Term Debt / Total Capital	0.78	0.89	1.5	2.58	2.65
Total Liabilities / Total Assets	24.02	27.03	25.55	27.2	26.78
EBIT / Interest Expense	71	40.44	34.5	48.44	39.36
EBITDA / Interest Expense	88.2	50.78	42.25	59.22	48.36
(EBITDA - Capex) / Interest Expense	72.2	43.11	35.33	50	40
Total Debt / EBITDA	0.11	0.39	0.12	0.21	0.17
Net Debt / EBITDA	-0.22	0.13	-0.22	-0.08	-0.28
Total Debt / (EBITDA - Capex)	0.14	0.46	0.15	0.25	0.21
Net Debt / (EBITDA - Capex)	-0.27	0.15	-0.26	-0.09	-0.34
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	20.73	18.84	3.78	-0.45	1.08
Gross Profit, 1 Yr. Growth %	12.85	9.3	8.6	6.15	2.4
EBITDA, 1 Yr. Growth %	13.98	3.47	11.19	4.83	-0.77
EBITA, 1 Yr. Growth %	14.24	2.65	12.92	5.03	-1.09
EBIT, 1 Yr. Growth %	15.26	2.54	13.74	5.31	-0.69
Earnings From Cont. Operations, 1 Yr. Growth %	14.93	2.36	8.85	6.71	1.32
Net Income, 1 Yr. Growth %	15	2.37	8.88	7.09	1.32
Normalized Net Income, 1 Yr. Growth %	15.09	-0.28	13.43	7.55	0
Diluted EPS Before Extra, 1 Yr. Growth %	15	2.82	11.74	9.76	1.77
Accounts Receivable, 1 Yr. Growth %	16.71	17.55	-1.38	3.59	-0.77
Inventory, 1 Yr. Growth %	41.23	25.25	-17.48	8.21	-0.18
Net Property, Plant and Equip., 1 Yr. Growth %	6.29	0.94	0	8.26	-3.2
Total Assets, 1 Yr. Growth %	9.01	9.17	-3.96	7.72	3.56
Tangible Book Value, 1 Yr. Growth %	14.17	6.63	-1	2.03	3.51
Common Equity, 1 Yr. Growth %	11.02	4.85	-2.07	5.39	4.16
Cash From Operations, 1 Yr. Growth %	-53.06	-24.26	324.22	-28.18	4.1
Capital Expenditures, 1 Yr. Growth %	-34.43	-13.75	20.29	0	10.84
Levered Free Cash Flow, 1 Yr. Growth %	-82.28	-2.46	1.09T	-44.83	22.11
Unlevered Free Cash Flow, 1 Yr. Growth %	-81.18	3.66	950.5	-44.5	22.11
Dividend Per Share, 1 Yr. Growth %	4.04	3.88	3.74	5.41	5.13
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	5.65	19.78	11.06	1.64	0.31
Gross Profit, 2 Yr. CAGR %	4.16	11.06	8.95	7.47	4.26
EBITDA, 2 Yr. CAGR %	5.11	8.6	7.26	7.96	1.99
EBITA, 2 Yr. CAGR %	4.53	8.29	7.66	8.91	1.93
EBIT, 2 Yr. CAGR %	4.35	8.71	7.99	9.44	2.27
Earnings From Cont. Operations, 2 Yr. CAGR %	5.55	8.47	5.55	7.77	3.98
Net Income, 2 Yr. CAGR %	5.34	8.5	5.58	7.98	4.17
Normalized Net Income, 2 Yr. CAGR %	3.59	7.13	6.36	10.45	3.71
Diluted EPS Before Extra, 2 Yr. CAGR %	5.34	8.74	7.19	10.74	5.69
Accounts Receivable, 2 Yr. CAGR %	6.33	17.13	7.67	1.07	1.38
Inventory, 2 Yr. CAGR %	15.36	33	1.66	-5.51	3.93
Net Property, Plant and Equip., 2 Yr. CAGR %	7.23	3.58	0.47	4.05	2.37
Total Assets, 2 Yr. CAGR %	6.88	9.09	2.39	1.71	5.62
Tangible Book Value, 2 Yr. CAGR %	4.17	10.34	2.74	0.5	2.77
Common Equity, 2 Yr. CAGR %	6.01	7.89	1.33	1.59	4.77
Cash From Operations, 2 Yr. CAGR %	-28.33	-40.37	79.25	74.55	-13.53
Capital Expenditures, 2 Yr. CAGR %	-27.92	-24.8	1.86	9.68	5.28
Levered Free Cash Flow, 2 Yr. CAGR %	-46.54	-58.43	240.16	155.84	-17.92
Unlevered Free Cash Flow, 2 Yr. CAGR %	-44.93	-55.83	230	141.46	-17.68
Dividend Per Share, 2 Yr. CAGR %	3.05	3.96	3.81	4.57	5.27
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	3.8	9.88	14.19	7.08	1.45
Gross Profit, 3 Yr. CAGR %	2.37	5.85	10.24	8.07	5.75
EBITDA, 3 Yr. CAGR %	1.35	4.56	9.46	6.44	4.97
EBITA, 3 Yr. CAGR %	0.18	3.9	9.81	6.78	5.47
EBIT, 3 Yr. CAGR %	-0.19	3.74	10.36	7.09	5.96
Earnings From Cont. Operations, 3 Yr. CAGR %	-4.1	4.48	8.59	5.94	5.58
Net Income, 3 Yr. CAGR %	-4.23	4.34	8.63	6.08	5.72
Normalized Net Income, 3 Yr. CAGR %	-2.1	2.28	9.19	6.75	6.85
Diluted EPS Before Extra, 3 Yr. CAGR %	-4.23	4.49	9.73	8.04	7.67
Accounts Receivable, 3 Yr. CAGR %	4.36	9.94	10.61	6.29	0.46
Inventory, 3 Yr. CAGR %	7.34	18.56	13.43	3.8	-3.76
Net Property, Plant and Equip., 3 Yr. CAGR %	12.61	5.09	2.37	3	1.57
Total Assets, 3 Yr. CAGR %	6.91	7.64	4.55	4.14	2.32
Tangible Book Value, 3 Yr. CAGR %	6.03	4.98	6.42	2.5	1.49
Common Equity, 3 Yr. CAGR %	6.41	5.62	4.46	2.67	2.44
Cash From Operations, 3 Yr. CAGR %	-14.14	-27	14.68	32.15	46.93
Capital Expenditures, 3 Yr. CAGR %	-12.88	-23.48	-12.05	1.23	10.06
Levered Free Cash Flow, 3 Yr. CAGR %	-25.42	-34.67	27.04	85.51	99.94
Unlevered Free Cash Flow, 3 Yr. CAGR %	-23.81	-32.01	27.02	82.15	92.37
Dividend Per Share, 3 Yr. CAGR %	2.73	3.32	3.89	4.34	4.75
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	4.84	6.65	6.64	6.51	8.42
Gross Profit, 5 Yr. CAGR %	2.57	3.61	4.95	6.49	7.84
EBITDA, 5 Yr. CAGR %	1.6	1.45	3.67	5.91	6.41
EBITA, 5 Yr. CAGR %	0.48	0.37	3.11	5.88	6.59
EBIT, 5 Yr. CAGR %	0.17	0.06	3.01	5.99	7.05
Earnings From Cont. Operations, 5 Yr. CAGR %	-0.47	-0.68	-0.35	5.78	6.72
Net Income, 5 Yr. CAGR %	-0.47	-0.75	-0.42	5.78	6.82
Normalized Net Income, 5 Yr. CAGR %	-0.66	-1.11	1.2	5.47	6.96
Diluted EPS Before Extra, 5 Yr. CAGR %	-0.47	-0.67	0.19	6.95	8.1
Accounts Receivable, 5 Yr. CAGR %	4.17	6.3	5.67	6.31	6.82
Inventory, 5 Yr. CAGR %	9.3	11.65	5.03	8.28	9.53
Net Property, Plant and Equip., 5 Yr. CAGR %	11.75	9.78	7.59	4.67	2.37
Total Assets, 5 Yr. CAGR %	6.64	7.58	5.08	5.23	4.98
Tangible Book Value, 5 Yr. CAGR %	9.59	7.95	4.71	3.17	4.94
Common Equity, 5 Yr. CAGR %	7.8	7.07	4.35	3.99	4.59
Cash From Operations, 5 Yr. CAGR %	-10.84	-11.96	15.25	3.46	2.43
Capital Expenditures, 5 Yr. CAGR %	-2.97	-8.05	-7.26	-11.63	-5.49
Levered Free Cash Flow, 5 Yr. CAGR %	-25.62	-19.1	36.85	12.78	6.67
Unlevered Free Cash Flow, 5 Yr. CAGR %	-24.63	-17.02	36.94	12.88	6.79
Dividend Per Share, 5 Yr. CAGR %	2.96	3.29	3.16	3.82	4.44